Crsp analyst ratings
WebApr 13, 2024 · Shares of CRISPR Therapeutics AG ( NASDAQ:CRSP - Get Rating) have received a consensus rating of "Hold" from the twenty analysts that are presently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the company. Web2 days ago · View real-time CRSP stock price and news, along with industry-best analysis. ... Analyst Ratings. Average price target from 29 ratings: $78.76. ... Fundamental …
Crsp analyst ratings
Did you know?
Web1 day ago · CRISPR Therapeutics (CRSP) jumped Thursday after Cantor Fitzgerald launched its coverage with an Overweight rating and a $72 per share target. Find out the reasons. WebCRSP Analyst Ratings Moderate Buy 17 Ratings 9 Buy 7 Hold 1 Sell Based on 17 analysts giving stock ratings to Crispr Therapeutics AG in the past 3 months CRSP …
Web23 hours ago · Shares of CRISPR Therapeutics (CRSP 16.31%) were up 15% Thursday morning, a day after a drug-pricing group said the company's single-dose therapy for … WebApr 14, 2024 · InvestorsObserver is giving Crispr Therapeutics AG (CRSP) an Analyst Rating Rank of 33, meaning CRSP is ranked higher by analysts than 33% of stocks. …
Web1 day ago · CRISPR Therapeutics (CRSP) jumped Thursday after Cantor Fitzgerald launched its coverage with an Overweight rating and a $72 per share target. Find out … Web20 hours ago · Cathie Wood Buys CRSP Stock Before Cantor Price Target Initiation. Cantor analyst Olivia Brayer has initiated coverage of Crispr with an “overweight” rating and a price target of $72.
Web1 day ago · Although CRSP has traded at a recent price of $43.47/share, the average analyst target is 100.69% higher at $87.24/share. Similarly, VCYT has 44.87% upside from the recent share price of $21.26 if ...
WebThe commodity reached a new 52-week high and recorded its second-highest close in history, just below a record high of $2,051.50 established in 2024. Thanks to this advance, AU closed at $28.06 ... difusor flash macroWeb2 days ago · CRISPR Therapeutics (CRSP) (Delayed Data from NSDQ) $44.80 USD +1.09 (2.49%) Updated Apr 5, 2024 03:59 PM ET After-Market: $44.60 -0.20 (-0.45%) 7:58 PM ET Add to portfolio Zacks Rank: 2-Buy 2... formulas of accounting ratios class 12WebCRISPR Therapeutics Stock (NASDAQ:CRSP), Analyst Ratings, Price Targets, Predictions Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 … formulas of 2d shapesWebApr 14, 2024 · InvestorsObserver is giving Crispr Therapeutics AG (CRSP) an Analyst Rating Rank of 33, meaning CRSP is ranked higher by analysts than 33% of stocks. The average price target for CRSP is $87.24 and analyst’s rate the stock as a Buy. Wall Street analysts are rating CRSP a Buy today. Find out what this means to you and get the rest … formulas not updating in excel until saveWebApr 10, 2024 · According to 35 stock analysts, the average 12-month stock price forecast for CRSP stock is $ 85.88 , which predicts an increase of 89.16%. The lowest target is $ … formulas of abacusWebApr 13, 2024 · Get Wall Street analysts ratings for CRISPR Therapeutics AG (CRSP). Buy or Sell this stock? See what the analysts say. formulas of a circleWebMar 21, 2024 · According to 11 analyst offering 12-month price targets in the last 3 months, CRISPR Therapeutics has an average price target of $71.91 with a high of $123.00 and … difusor gama italy